Quarterly EPS earnings growth: IGC Pharma Inc (IGC)

Brandmark of IGC Pharma Inc (IGC)

Alzheimer's drug development for IGC Pharma, Inc. (IGC) remains stalled at the clinical trial stage while R&D expenses continue to climb. Geopolitical tensions are blocking international research, disrupting the delivery of biomaterials. However, high barriers to entry driven by patents and FDA oversight are confirmed by this quarterly earnings per share chart for the GURU.Markets platform, where the indicator value reaches 6.90, capturing risk limits.

India Globalization Capital (IGC) - Year-over-year net earnings per share growth for the last 12 months from 07/04/2022 to 11/16/2026

Analytical breakdowns for igcinc.us (IGC)

- share price and expert price forecast:
- company stock exchange capitalization indicators:
Summary company analytics:IGC Pharma Inc - IGC
Manufactured product of IGC Pharma, Inc.

This indicator measures the rate of change in earnings per share over the last three months, allowing for an assessment of capital generation efficiency relative to the market price. Analyzing quarterly EPS growth is critical for IGC Pharma, Inc. (IGC), as investments in the development of the IGC-AD1 drug may temporarily reduce profits prior to the release of breakthrough clinical data.

Competitor analysis

Indivior Corp (INDV) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months Collegium Pharmaceutical Inc|CRON (thecronosgroup.com) - Quarterly EPS earnings growth|Quarterly EPS earnings growth canopygrowth.com|Quarterly EPS earnings growth HITI|ACB (Aurora Cannabis, Inc.) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth ACHV (Achieve Life Sciences, Inc)|Skye Bioscience (SKYE) - Earnings per share growth in annualized terms for the last twelve months|Anebulo Pharmaceuticals - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months InterCure|NTRB: Quarterly EPS earnings growth|NSRX - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months MIRA Pharma|FLGC: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months IMC (IMCC)|ADIL: Year-over-year net earnings per share trend for the last twelve months|Quarterly EPS earnings growth ARTL (Artelo)|Year-over-year earnings per one share growth for the last 12 months ENSC|Titan Pharmaceuticals - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Greenlane Holdings|inmedpharma.com (INM) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months AKAN|Year-over-year earnings per share growth for the last twelve months Enveric Corp|Earnings per share growth in annualized terms for the last twelve months brightgreen.us BGXX|Year-over-year net earnings per share growth for the last 12 months HPCO (Hempacco Co Inc.)